Huaren Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Huaren Pharmaceutical Co Ltd with three other
companies in this sector in China:
Fuan Pharmaceutical Group Co Ltd
sales of 1.30 billion Chinese Renmimbi [US$196.99 million]
of which 100%
was Pharmaceutical Industry),
Porton Fine Chemicals Ltd
(1.33 billion Chinese Renmimbi [US$201.48 million]
of which 81%
was Pharmaceutical R&D Production), and
Tianjin Tianyao Pharmaceutical, Ltd.
(1.21 billion Chinese Renmimbi [US$183.25 million]
During the year ended December of 2016, sales at
Huaren Pharmaceutical Co Ltd were 1.25 billion Chinese Renmimbi (US$189.69 million).
increase of 12.9%
versus 2015, when the company's sales were 1.11 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Huaren Pharmaceutical Co Ltd
(and since 2011, sales have increased a total of 208%).
Sales of Medicine Commerce saw an increase
that was more than double the company's growth rate: sales were up
26.2% in 2016, from
197.19 million Chinese Renmimbi to 248.85 million Chinese Renmimbi.